Sex Hormones and Aging
Part of paid clinical trials in Ann Arbor, Michigan.
- Sponsor
- University of Michigan
- Study ID
- NCT07848438
- Status
- Recruiting
Conditions
- Aging
- Menopausal Hormone Therapy
- Menopause
Eligibility Criteria
- Sex
- FEMALE
- Age
- 50 Years - 70 Years
- Healthy Volunteers
- Accepted
Interventions
- HRT: High-Resistance Strength Training — OTHEREach participant will attend 2 sessions per week for 8 weeks. A training session will start with a 10-minute full body dynamic warm-up (e.g., bodyweight movements and mobility exercises). The participant will then perform bilateral lower body high-resistance strength training exercises (leg extension and leg press) for 4 sets of 8-10 repetitions.
- Control: High-Resistance Strength Training — OTHEREach participant will attend 2 sessions per week for 8 weeks. A training session will start with a 10-minute full body dynamic warm-up (e.g., bodyweight movements and mobility exercises). The participant will then perform bilateral lower body high-resistance strength training exercises (leg extension and leg press) for 4 sets of 8-10 repetitions.
Study Details
This study investigates the influence of sex hormones and exercise on age-related neuromuscular decline in females. Specifically, the research aims to evaluate how hormonal variations impact both age-associated neuromuscular decline and the subsequent adaptations to exercise and resistance training. Age-related declines in neuromuscular function are especially pronounced in females, potentially due to the sharp drop in estradiol after menopause. This project will compare postmenopausal females who have not taken hormonal therapy (HT) to age-matched females taking HT.
Key Dates
- First listed
- Sep 30, 2026
- Start date
- Aug 20, 2026
- Status verified
- Sep 2026
- Primary completion
- Aug 31, 2031
- Completion
- Aug 31, 2031
Study Design
- Enrollment
- 120 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Postmenopausal Hormone TherapyPostmenopausal females who are currently taking hormone replacement therapy
- Experimental: Postmenopausal Female ControlsPostmenopausal females who have no history of taking hormone replacement therapy
Primary Outcome Measure
Strength - Maximal Voluntary Contraction (MVC) [ Time Frame: One session before and then after 8 weeks of training ]
Central Contacts
- Sandra Hunter, PhD(734) 647-9819
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Michigan | Ann Arbor | Michigan | 48109 | Sarah Lessila, MS |
Find similar trials in Ann Arbor, MI
By condition
By specialty
By research site
Related Studies
- Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized EldersRecruiting · University of Michigan · Orange, California
- Motivating Activity Through Text Communications - Helping Adults Increase MovementRecruiting · University of Michigan · Ann Arbor, Michigan
- Baltimore Longitudinal Study of AgingRecruiting · National Institute on Aging (NIA) · Baltimore, Maryland
- The Lake Nona Life ProjectRecruiting · University of Central Florida · Orlando, Florida